BioCrude Technologies USA, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
BioCrude Technologies USA, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$281.13 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-08-24
- BioCrude Technologies USA, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-06-30 was -$48.77K.
- BioCrude Technologies USA, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$232.36K.
- BioCrude Technologies USA, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was $118.96K.
- BioCrude Technologies USA, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$133.01K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month |
|---|---|---|---|---|
| 2018-06-30 | -$48.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-24 | -$281.13K 10-Q · filed 2018-08-24 | ||
| 2018-03-31 | -$232.36K 10-Q · filed 2018-05-16 | |||
| 2017-09-30 | $118.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$14.04K derived: sum of 2 quarters · filed 2018-08-24 | -$44.61K 10-Q · filed 2017-10-24 | |
| 2017-06-30 | -$133.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-24 | -$163.57K 10-Q · filed 2018-08-24 | -$31.32K 10-Q · filed 2017-09-12 | |
| 2017-03-31 | -$30.57K 10-Q · filed 2018-05-16 | |||
| 2016-09-30 | -$34.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$106.65K 10-Q · filed 2017-10-24 | ||
| 2016-06-30 | -$72.12K 10-Q · filed 2017-09-12 |